normal
plasma
arginine
esterase
and
the
hageman
factor
factor
xii
prekallikrein
kininogen
system
in
cystic
fibrosis
previous
investigators
have
suggested
that
the
biological
activity
of
plasma
prekallikrein
is
defective
in
cystic
fibrosis
in
contrast
no
such
difference
was
demonstrable
between
normal
and
cystic
fibrosis
plasma
esterolytic
activity
for
the
synthetic
substrate
p
toluene
sulfonyl
arginine
methyl
ester
tame
evolved
normally
in
cystic
fibrosis
plasma
treated
with
chloroform
and
ellagic
acid
a
measure
of
generation
of
plasma
kallikrein
additionally
plasma
prekallikrein
fletcher
factor
and
high
molecular
weight
kininogen
fitzgerald
factor
a
substrate
of
plasma
kallikrein
were
normal
thus
the
concept
that
cystic
fibrosis
is
associated
with
abnormalities
in
the
plasma
kallikrein
kinin
system
could
not
be
supported
